Microbiome Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Microbiome Therapeutics Landscape

YSOPIA Bioscience
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

4D pharma plc
Enterome
BiomX Inc.
Ferring International Center S.A.
Vedanta Biosciences, Inc.
Seres Therapeutics, Inc.
Assembly Biosciences, Inc.
Synlogic
Finch Therapeutics Group, Inc.

Browse Key Market Insights with Data Illustration:

Microbiome Therapeutics Market Size, Growth Forecasts 2025-2037

In the News

Enterome has introduced the world's first clinical data with EO2401, its first-in-class off-the-shelf OncoMimics therapeutic cancer vaccine, at the American Society of Clinical Oncology (ASCO) Annual Meeting.
Ferring International Center S.A. has received approval from the U.S. FDA for REBYOTA (fecal microbiota, live-jslm). It is a novel first-in-class microbiota-based live biotherapeutic denoted for the inhibition of recurrence of Clostridioides difficile infection (CDI) in individuals of 18 years of age and older, following antibiotic treatment for recurrent CDI.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of microbiome therapeutics is assessed at USD 632.54 million.

The microbiome therapeutics market size was valued at USD 531.37 million in 2024 and is set to reach USD 8.59 billion by the end of 2037, expanding at around 23.6% CAGR during the forecast period i.e., between 2025-2037. Rise in the investments of microbiome modulators, worldwide growing prevalence of diabetes, and an increase in the development of novel microbiome will boost the market growth.

North America is expected to dominate majority industry share of about 40% by 2037, propelled by significant presence of numerous established research facilities in the region for the development of novel therapeutics, followed by rising healthcare expenditure and the presence of a population who are highly conscious of their health.

The major players in the market include YSOPIA Bioscience, 4D pharma plc, Enterome, BiomX Inc., Ferring International Center S.A., Vedanta Biosciences, Inc., Seres Therapeutics, Inc., Assembly Biosciences, Inc., Synlogic, Finch Therapeutics Group, Inc.

Microbiome Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Microbiome Therapeutics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the microbiome therapeutics market worth?

Why is the demand for microbiome therapeutics growing?

Which region dominated the majority of microbiome therapeutics industry share?

Who are the top microbiome therapeutics companies?